GSK plc to acquire the acceptance for its new drug application from US Food and Drug Administration (FDA). This new drug application (NDA) has been developed for the treatment of myelofibrosis patients with anemia.
Sunovion Pharmaceuticals Inc. to provide support for the Next Generation of Innovators with the Red Sox Foundation. The program is entirely on assisting the scholars who are exploring STEM and life sciences. Furthermore, the program is also becoming advantageous for students to receive better mentoring and coaching.
Author Credits: Radhika Gupta, Shivam Bhutani